Statements (32)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:approvalYear |
1998
|
| gptkbp:ATCCode |
R03DC03
|
| gptkbp:blackBoxWarning |
serious mental health side effects
|
| gptkbp:brand |
gptkb:Singulair
|
| gptkbp:chemicalFormula |
C35H36ClNO3S
|
| gptkbp:contraindication |
hypersensitivity to montelukast
|
| gptkbp:eliminationHalfLife |
2.7–5.5 hours
|
| gptkbp:excretion |
bile
|
| gptkbp:form |
gptkb:tablet
chewable tablet granules |
| gptkbp:genericAvailable |
yes
|
| gptkbp:genericName |
gptkb:montelukast
|
| https://www.w3.org/2000/01/rdf-schema#label |
Singulair
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:manufacturer |
gptkb:Merck_&_Co.
|
| gptkbp:mechanismOfAction |
leukotriene receptor antagonist
|
| gptkbp:metabolism |
liver
|
| gptkbp:patentExpired |
2012 (US)
|
| gptkbp:pregnancyCategory |
B (US)
|
| gptkbp:prescribes |
adults
children |
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
abdominal pain
headache cough neuropsychiatric effects |
| gptkbp:usedFor |
asthma
allergic rhinitis |
| gptkbp:bfsParent |
gptkb:Merck_&_Co.
|
| gptkbp:bfsLayer |
4
|